News & Views
Dominion Diagnostics Creates New Model for Drug Monitoring
May 23 2008
individualise treatment for patients in their care.
Scientifically Accurate Medication Monitoring (SAMMTM ) includes a validated comprehensive screen for pain medications and their associated
metabolites along with interpretation and support from the companyâs team of clinical pharmacologists and MDâs. The reports contain information on prescribed and abused pain medications, also on the drug source.
In early 2006, Dominion was the first laboratory specialising in clinical quantitative urine drug testing for pain and addiction medicine, to add liquid chromatography/tandem mass spectrometry (LC/MS/MS) to its test menu through the acquisition of WatersÂ® ACQUITY
UltraPerformance LCÂ® (UPLCÂ®)/TQD and Quattro microâ¢ Mass Spectrometry (MS) systems.
To meet patient pharmacotherapy demands in 2008, Dominion is said to be increasing its capacity to a total of 11 UPLC/MS/MS systems in its laboratory.
âWatersâ technology and clinical applications expertise have enabled our business to get to another level in terms of the services, like
SAMM, that we can offer our clients,â said Dr. Frank Fornari, CEO of Dominion Diagnostics. âThe technology has allowed us to create a
new model for clinical drug monitoring in pain management and addiction medicine.â
Dr. Robert L. Barkin, an Associate Professor, Faculty of Anesthesiology, Family Medicine and Pharmacology, at Rush University Medical Center, Chicago,commented; âWatersâ solutions, coupled with Dominionâs SAMM, offers the most comprehensive, scientifically-backed data that has ever been available to our industry.
Now that we have the ability to interpret individual patient pharmacotherapy with this information, we can better focus our efforts on improving the quality of life and functional status of both our patients and their families.â
Buyers Guide - Major producers of analytical equipment who wish to introduce and sell their products to buyers in science and industry - Over 1,000 products and services that these companys man...
View all digital editions
Jan 17 2024 Birmingham, UK
Jan 24 2024 Tokyo, Japan
Jan 29 2024 Dubai, UAE
Jan 31 2024 Tokyo, Japan
Feb 03 2024 Boston, MA, USA